Saavedra Oscar M, Isakovic Ljubomir, Llewellyn David B, Zhan Lijie, Bernstein Naomy, Claridge Stephen, Raeppel Franck, Vaisburg Arkadii, Elowe Nadine, Petschner Andrea J, Rahil Jubrail, Beaulieu Norman, MacLeod A Robert, Delorme Daniel, Besterman Jeffrey M, Wahhab Amal
MethylGene Inc., Departments of Medicinal Chemistry, Montreal, Quebec, Canada.
Bioorg Med Chem Lett. 2009 May 15;19(10):2747-51. doi: 10.1016/j.bmcl.2009.03.113. Epub 2009 Mar 28.
The inhibitory activity of base-modified SAH analogues and the specificity of inhibiting human DNMT1 and DNMT3b2 enzymes was explored. The 6-amino group was essential while the 7-N of the adenine ring of SAH could be replaced by CH- without loss of activity against both enzymes. The introduction of small groups at the 2-position of the adenine moiety favors DNMT1 over DNMT3b2 inhibition whereas alkylation of the N(6)-amino moiety favors the inhibition of DNMT3b2 enzyme.
研究了碱基修饰的SAH类似物的抑制活性以及对人DNMT1和DNMT3b2酶抑制的特异性。6-氨基基团至关重要,而SAH腺嘌呤环的7-N可以被CH-取代,而不会丧失对这两种酶的活性。在腺嘌呤部分的2-位引入小基团有利于对DNMT1的抑制而非DNMT3b2,而N(6)-氨基部分的烷基化则有利于对DNMT3b2酶的抑制。